Compare BioNTech SE - ADR (BNTX) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Lowe`s Companies Inc — how do they compare? BioNTech SE - ADR trades at $90.35 (market cap $22.86B), while Lowe`s Companies Inc trades at $210.66 (market cap $116.45B). The key difference: Lowe`s Companies Inc is far larger — about 5.1× BioNTech SE - ADR's market cap, and Lowe`s Companies Inc pays a 2.41% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | LOW | |
|---|---|---|
Market Cap | $22.86B | $116.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $287.39 |
52-Week Low | $83.89 | $206.62 |
Enterprise Value | $6.53B | $158.20B |
Dividend Yield | — | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lowe's (LOW) trades at $207.70, down 1.86% on the day, with a bearish technical signal from moving averages but oversold short-term RSI. The company maintains solid profitability with a 7.51% net margin and has beaten EPS estimates for three consecutive quarters. Revenue declined to $83.67B in 2025, though cash flow from operations improved to $9.63B. Recent news highlights Lowe's dividend growth strategy, with the quarterly payout rising to $1.25.
The outlook is mixed: strong analyst consensus (60.79% buy ratings) and a $260.88 price target suggest upside, but technical weakness and high debt levels pose risks. Earnings stability and dividend growth support long-term value, though housing market sensitivity and competitive pressures remain headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
